4
Chemists of RUDN showed how new antineoplastic medicine interacts with proteins of blood

Chemists of RUDN showed how new antineoplastic medicine interacts with proteins of blood

Chemists of RUDN in details investigated the molecular mechanism of interaction of recently created antineoplastic preparation with proteins of blood. Results not only will allow to judge efficiency of means, but also are of interest from the point of view of understanding of mechanisms of action of similar drugs.

Heterocyclic compounds, in which there are several organic “rings” with atoms of other elements, are of interest to chemists and pharmacists due to a wide range of biological activity. Previously, RUDN University created a heterocyclic compound with a pronounced antitumor effect. In structure, it resembles the drugs aphthazole and panoprofen, which are usually used to combat inflammation. At the same time, the mechanism of their action is not fully known to scientists. One of the indicators of the effectiveness of the drug is its binding to blood proteins, so the study of this process is important for understanding the work of the drug. RUDN chemists continued to study the new drug and studied the features of its biophysical interaction with the body. To do this, they investigated how the drug binds to the protein cyclooxygenase-1 (PTGS1) and bovine serum albumin (BSA).

“Sincethe molecules of the created drug compound are similar to the commercial drugs pranoprofenom and aphthazole,itis interesting to understand the mechanism of its binding interaction with PTGS1 using various biophysical methods. Understanding the interaction with BSA is important because it is a well-known model of proteinmolecules a, which can take various drugs and transfer them to a given molecular environment,” said Alexey Festa, Candidate of Chemical Sciences, Senior Lecturer at the Department of Organic Chemistry of RUDN University.

The chemists investigated the drug’s interaction with BSA and PTGS1 experimentally and theoretically, using fluorescence spectroscopy (fluorimetry)as well as computer molecular modeling. Fluorimetry allows you to determine the concentration of a substance by the intensity of fluorescence, which occurs when it is irradiated with a substance.

Fluorescence spectroscopy showed that when the drug interacts with albumin, the effect of the so-called static quenching occurs. This means that the substances have combined with each other, and a non-fluor natural product isobtained. This effect (together with subsequent theoretical simulation results) suggests that the compound follows the principle of hydrophobic interaction. It determines how the structure of the compound will look as a result. Molecular modeling using the molecular docking method showed that in conjunction with BSA and PTGS1, the drug is stable during the entire simulation time.

“Molecular docking studies show that the drug has a goodbinding ability both in combination with BSA and in combination with PTGS. At the same time, the theoretically calculated energyof the connection almost coincides with the one calculated experimentally.Analysis ofmolecular dynamics shows that the drug is stable both in the complex system with BSA and in the system with PTGS1,” — Cubramani Kartikean, postdoc Department of Organic Chemistry rudn University.

The results are  in the Journal of Molecular Structure.

International scientific cooperation View all
12 Dec 2024
From 19 to 23 November 2024, RUDN hosted the III International Scientific Conference ‘For the Sustainable Development of Civilisation: Cooperation, Science, Education, Technology’. The event gathered more than 2000 participants from 72 countries.
482
Scientific Conferences View all
12 Dec 2024
About 200 participants from Russia and 20 countries met at the National Interdisciplinary Scientific Seminar with International Participation “Law in Medicine. Medicine in Law: Points of Contact”. The subject was “Happy Motherhood: unsolved problems of obstetrics, gynaecology and perinatology”.
370
Similar newsletter View all
08 Aug
Focusing on science as a way of life, sustainable development goals as a scientist's mission and new technological developments: RUDN honored leaders in science and innovation

The RUDN University Science and Innovation Prize winners were honoured at the extended meeting of the Academic Council. In 2024 the terms of the traditional RUDN University Prize were changed: for the first time the competition was announced in two categories: leading scientists and young scientists.

114
08 Aug
RUDN University scientist: Africa relies on small modular reactors to solve energy problems

According to the International Energy Agency (IEA), electricity consumption in Africa has increased by more than 100% over the past two years (2020-2022). However, 74.9% of this energy is still produced by burning organic fuels — natural gas, coal and oil. At the same time, the level of electrification on the continent remains extremely low — only 24%, while in other developing countries it reaches 40%. Even in grid-connected areas, electricity supply is often unreliable: industrial enterprises lose energy on an average of 56 days a year.

102
08 Aug
RUDN dentists developed a program that will accelerate the work of an orthodontist by 40%

Today, diagnosis and treatment planning with orthodontists takes several days. Also, complications can arise during treatment that slow down the patient's recovery process. For example, improper orthodontic treatment planning can lead to temporomandibular joint dysfunction.

64
Similar newsletter View all